JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.01B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.93B |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.27B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$920M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$909M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$2.61B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.47B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.26B |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$990M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.29% |
| 2 | Technology | 12.89% |
| 3 | Financials | 12.24% |
| 4 | Healthcare | 8.95% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3376
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.4B
| $1.68M | ﹤0.01% |
+31,427
| New | +$1.67M |
2019 Q3
0 quarters
|
|
|
APTS
3377
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $1.68M | ﹤0.01% |
116,153
-87,135
| -43% | -$1.26M |
2016 Q4
11 quarters
|
|
3378
CALL
Newell Brands
NWL
$2.3B
| $1.68M | ﹤0.01% |
89,500
-45,100
| -34% | -$727K |
2019 Q2
1 quarter
|
|
|
CRON
3379
PUT
Cronos Group
CRON
$1.19B
| $1.67M | ﹤0.01% |
+184,700
| New | +$2.36M |
2019 Q3
0 quarters
|
|
|
ACRE
3380
Ares Commercial Real Estate
ACRE
$214M
| $1.67M | ﹤0.01% |
109,684
+32,818
| +43% | +$500K |
2015 Q3
16 quarters
|
|
3381
Resources Connection
RGP
$135M
| $1.66M | ﹤0.01% |
97,938
+29,499
| +43% | +$496K |
2013 Q2
25 quarters
|
|
|
SUP
3382
DELISTED
Superior Industries International
SUP
| $1.66M | ﹤0.01% |
575,446
+42,970
| +8% | +$125K |
2015 Q4
15 quarters
|
|
|
HPR
3383
DELISTED
HighPoint Resources Corporation
HPR
| $1.65M | ﹤0.01% |
20,797
-23,931
| -54% | -$1.66M |
2018 Q1
6 quarters
|
|
|
PDLI
3384
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.65M | ﹤0.01% |
765,069
+632,294
| +476% | +$1.69M |
2013 Q2
25 quarters
|
|
3385
Perdoceo Education
PRDO
$2.02B
| $1.65M | ﹤0.01% |
103,763
+43,780
| +73% | +$859K |
2015 Q4
15 quarters
|
|
3386
Pacific Biosciences
PACB
$780M
| $1.65M | ﹤0.01% |
319,384
+6,568
| +2% | +$36.7K |
2017 Q4
7 quarters
|
|
3387
OR Royalties Inc
OR
$6.43B
| $1.64M | ﹤0.01% |
+175,930
| New | +$2.07M |
2019 Q3
0 quarters
|
|
3388
CALL
Fastenal
FAST
$58.1B
| $1.63M | ﹤0.01% |
+100,000
| New | +$1.56M |
2019 Q3
0 quarters
|
|
|
HES
3389
CALL
DELISTED
Hess
HES
| $1.63M | ﹤0.01% |
+27,000
| New | +$1.68M |
2019 Q3
0 quarters
|
|
|
MSB
3390
Mesabi Trust
MSB
$247M
| $1.63M | ﹤0.01% |
68,080
-5,124
| -7% | -$131K |
2016 Q3
12 quarters
|
|
3391
Schneider National
SNDR
$5.78B
| $1.63M | ﹤0.01% |
74,931
-263,592
| -78% | -$5.19M |
2017 Q2
9 quarters
|
|
3392
Kornit Digital
KRNT
$738M
| $1.62M | ﹤0.01% |
52,660
+35,686
| +210% | +$1.06M |
2017 Q1
10 quarters
|
|
3393
PUT
First Horizon
FHN
$11B
| $1.62M | ﹤0.01% |
+100,000
| New | +$1.58M |
2019 Q3
0 quarters
|
|
3394
Icahn Enterprises
IEP
$4.81B
| $1.62M | ﹤0.01% |
25,215
+22,366
| +785% | +$1.59M |
2015 Q1
18 quarters
|
|
3395
BBVA Argentina
BBAR
$2.55B
| $1.62M | ﹤0.01% |
373,660
-651,285
| -64% | -$5.07M |
2018 Q1
6 quarters
|
|
3396
IMAX
IMAX
$2.89B
| $1.61M | ﹤0.01% |
73,504
+4,637
| +7% | +$98.4K |
2014 Q2
21 quarters
|
|
3397
Oppenheimer Holdings
OPY
$1.3B
| $1.61M | ﹤0.01% |
53,572
+18,016
| +51% | +$518K |
2013 Q2
25 quarters
|
|
3398
Oaktree Specialty Lending
OCSL
$1.05B
| $1.61M | ﹤0.01% |
103,393
+31,681
| +44% | +$499K |
2013 Q2
25 quarters
|
|
|
ZGNX
3399
DELISTED
Zogenix, Inc.
ZGNX
| $1.6M | ﹤0.01% |
40,087
+2,215
| +6% | +$102K |
2015 Q4
15 quarters
|
|
|
ITCI
3400
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.6M | ﹤0.01% |
214,824
+4,293
| +2% | +$41.2K |
2017 Q3
8 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2019 Portfolio in Review
As of Q3 2019, JP Morgan Chase held 6,188 positions worth $502B, down 1.8% from $511B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2019 filing shows 385 new, 2,786 increased, 1,863 reduced and 426 closed positions. Its largest new stake was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2019 buy was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M.
- JP Morgan Chase added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $2.01B increase.
- JP Morgan Chase's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- JP Morgan Chase fully exited Worldpay, Inc. in Q3 2019, selling an estimated $372M.
- JP Morgan Chase's ten largest holdings make up 16% of its $502B portfolio in Q3 2019.
- JP Morgan Chase opened 385 new positions and closed 426 in Q3 2019.
- JP Morgan Chase's portfolio value fell 1.8% quarter-over-quarter to $502B.
Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.